United States Biotechnology & Medical Research

Senseonics Holdings Inc (SENS)

Track

Track

Senseonics Holdings Inc. recorded one insider purchase totaling approximately $125,300 over the past ninety days. This activity follows a recent earnings report where the company missed expectations. Despite share price volatility, the stock has gained over 50% during this period, reflecting significant market movement preceding the next scheduled financial disclosure.
Ticker: SENS Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Senseonics Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
375.20
Quantity 40,526 -26.1%
Value US$793,823
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
363.84
Quantity 63,580 +47.3%
Value US$4,782,460
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
469.19
Quantity 87,579 -15.8%
Value US$2,923,968
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
5.73
Quantity 17,500 +17.1%
Value US$100,275
2.4
Steven Edelman Non-Executive Director
Transaction date
Purchase
Price
6.55
Quantity 10,000 +15.5%
Value US$65,500
3.8
Sullivan Frederick T. Chief Financial Officer Officer
Transaction date
Purchase
Price
5.88
Quantity 5,415 +3.6%
Value US$31,840
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
5.83
Quantity 15,000 +17.7%
Value US$87,450
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 25,000 +1.8%
Value US$12,500
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.41
Quantity 300,000 +27.6%
Value US$123,000
3.8
Sullivan Frederick T. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 124,933 +5.3%
Value US$47,475
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
0.31
Quantity 315,000 +2.9%
Value US$97,650
Larkin Sharon Non-Executive Director
Transaction date
Planned sale
Price
0.61
Quantity 30,889 -9.6%
Value US$18,842
SHARON D LARKIN Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 30,889
Value US$19,151
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.54
Quantity 300,000 +59.1%
Value US$162,000
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.97
Quantity 50,000 -2.0%
Value US$98,500
2.4
Fiorentino Edward Non-Executive Director
Transaction date
Sale
Price
1.65
Quantity 63,553 -12.9%
Value US$104,862
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Sale
Price
2.46
Quantity 163,870 -11.8%
Value US$403,120
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Sale
Price
2.46
Quantity 464,390 -8.9%
Value US$1,142,399
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Sale
Price
2.46
Quantity 150,197 -7.5%
Value US$369,485
3.3
Panlilio Mirasol VP Global Sales and Marketing Officer
Transaction date
Sale
Price
2.46
Quantity 105,760 -8.9%
Value US$260,170
3.3
Tressler Nick B. Chief Financial Officer Officer
Transaction date
Sale
Price
2.46
Quantity 72,873 -19.2%
Value US$179,268
3.3
Horton Kenneth L GC & Corp. Development Advisor Officer
Transaction date
Sale
Price
2.46
Quantity 143,126 -10.5%
Value US$352,090
Raab Anthony R. Non-Executive Director
Transaction date
Planned sale
Price
2.53
Quantity 136,538 -38.6%
Value US$345,441
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.70
Quantity 100,000 -5.4%
Value US$370,000
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
3.70
Quantity 20,998 -1.9%
Value US$77,693
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
4.36
Quantity 50,000 -2.5%
Value US$218,000
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
4.00
Quantity 62,628 -5.6%
Value US$250,512
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
3.60
Quantity 380,710 -7.3%
Value US$1,370,556
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.51
Quantity 18,866 -0.9%
Value US$66,220
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.50
Quantity 6,134 -0.3%
Value US$21,469
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
3.00
Quantity 62,627 -5.4%
Value US$187,881
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.70
Quantity 25,000 -1.3%
Value US$67,500
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
1.91
Quantity 147,735 -54.1%
Value US$282,174
Prince Douglas S Non-Executive Director
Transaction date
Planned sale
Price
1.90
Quantity 136,539 -37.1%
Value US$259,424
2.4
Fiorentino Edward Non-Executive Director
Transaction date
Planned sale
Price
1.91
Quantity 109,231 -24.7%
Value US$208,631
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Sale
Price
2.08
Quantity 652 -100.0%
Value US$1,358
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.12
Quantity 47,580 -98.6%
Value US$100,884
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.12
Quantity 4,906,326 -100.0%
Value US$10,402,883
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.39
Quantity 46,989 -49.3%
Value US$112,191
4.1
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.39
Quantity 4,845,399 -50.0%
Value US$11,568,875
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
0.71
Quantity 80,000 -15.5%
Value US$56,800
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
1.28
Quantity 80,000 -15.8%
Value US$102,400
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
1.10
Quantity 88,500 +26.3%
Value US$97,350
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
4.50
Quantity 40,000 -100.0%
Value US$180,196
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
4.05
Quantity 5,910 -5.8%
Value US$23,930
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
4.05
Quantity 605,355 -5.8%
Value US$2,451,082
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 1,501 -1.5%
Value US$5,951
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 153,723 -1.5%
Value US$609,435
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 2,068 -2.0%
Value US$8,199
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 211,832 -2.0%
Value US$839,829
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.91
Quantity 2,536 -2.4%
Value US$9,903
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.91
Quantity 259,690 -2.4%
Value US$1,014,115
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-19 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
40,526 -26.1%
375.20
US$793,823 		40,526 -26.1% 375.20 US$793,823
2026-05-13 2026-05-12 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
63,580 +47.3%
363.84
US$4,782,460 		63,580 +47.3% 363.84 US$4,782,460
2026-03-16 2026-03-13 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
87,579 -15.8%
469.19
US$2,923,968 		87,579 -15.8% 469.19 US$2,923,968
2026-03-16 2026-03-13 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
17,500 +17.1%
5.73
US$100,275 		17,500 +17.1% 5.73 US$100,275
2025-11-13 2025-11-10 B Purchase
2.4
Steven Edelman
Non-Executive Director
10,000 +15.5%
6.55
US$65,500 		10,000 +15.5% 6.55 US$65,500
2025-11-10 2025-11-07 B Purchase
3.8
Sullivan Frederick T.

Chief Financial Officer

Officer
5,415 +3.6%
5.88
US$31,840 		5,415 +3.6% 5.88 US$31,840
2025-11-10 2025-11-07 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
15,000 +17.7%
5.83
US$87,450 		15,000 +17.7% 5.83 US$87,450
2024-12-16 2024-12-13 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
25,000 +1.8%
0.50
US$12,500 		25,000 +1.8% 0.50 US$12,500
2024-12-16 2024-12-12 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
300,000 +27.6%
0.41
US$123,000 		300,000 +27.6% 0.41 US$123,000
2024-12-12 2024-12-12 B Purchase
3.8
Sullivan Frederick T.

Chief Financial Officer

Officer
124,933 +5.3%
0.38
US$47,475 		124,933 +5.3% 0.38 US$47,475
2024-12-10 2024-12-10 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
315,000 +2.9%
0.31
US$97,650 		315,000 +2.9% 0.31 US$97,650
2023-09-08 2023-09-07 PlS Planned sale
Larkin Sharon
Non-Executive Director
30,889 -9.6%
0.61
US$18,842 		30,889 -9.6% 0.61 US$18,842
2023-09-07 2023-09-07 PrS Proposed sale
SHARON D LARKIN

Officer

Officer
30,889
0.62
US$19,151 		30,889 0.62 US$19,151
2023-08-31 2023-08-30 B Purchase
4.1
ROEDER DOUGLAS A
Non-Executive Director
300,000 +59.1%
0.54
US$162,000 		300,000 +59.1% 0.54 US$162,000
2022-08-05 2022-08-04 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
50,000 -2.0%
1.97
US$98,500 		50,000 -2.0% 1.97 US$98,500
2022-03-15 2022-03-11 S Sale
2.4
Fiorentino Edward
Non-Executive Director
63,553 -12.9%
1.65
US$104,862 		63,553 -12.9% 1.65 US$104,862
2022-02-14 2022-02-11 S Sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
163,870 -11.8%
2.46
US$403,120 		163,870 -11.8% 2.46 US$403,120
2022-02-14 2022-02-11 S Sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
464,390 -8.9%
2.46
US$1,142,399 		464,390 -8.9% 2.46 US$1,142,399
2022-02-14 2022-02-11 S Sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
150,197 -7.5%
2.46
US$369,485 		150,197 -7.5% 2.46 US$369,485
2022-02-14 2022-02-11 S Sale
3.3
Panlilio Mirasol

VP Global Sales and Marketing

Officer
105,760 -8.9%
2.46
US$260,170 		105,760 -8.9% 2.46 US$260,170
2022-02-14 2022-02-11 S Sale
3.3
Tressler Nick B.

Chief Financial Officer

Officer
72,873 -19.2%
2.46
US$179,268 		72,873 -19.2% 2.46 US$179,268
2022-02-14 2022-02-11 S Sale
3.3
Horton Kenneth L

GC & Corp. Development Advisor

Officer
143,126 -10.5%
2.46
US$352,090 		143,126 -10.5% 2.46 US$352,090
2021-12-08 2021-12-06 PlS Planned sale
Raab Anthony R.
Non-Executive Director
136,538 -38.6%
2.53
US$345,441 		136,538 -38.6% 2.53 US$345,441
2021-11-18 2021-11-16 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
100,000 -5.4%
3.70
US$370,000 		100,000 -5.4% 3.70 US$370,000
2021-11-18 2021-11-16 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
20,998 -1.9%
3.70
US$77,693 		20,998 -1.9% 3.70 US$77,693
2021-06-16 2021-06-14 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
50,000 -2.5%
4.36
US$218,000 		50,000 -2.5% 4.36 US$218,000
2021-06-15 2021-06-11 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
62,628 -5.6%
4.00
US$250,512 		62,628 -5.6% 4.00 US$250,512
2021-06-14 2021-06-10 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
380,710 -7.3%
3.60
US$1,370,556 		380,710 -7.3% 3.60 US$1,370,556
2021-06-11 2021-06-10 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
18,866 -0.9%
3.51
US$66,220 		18,866 -0.9% 3.51 US$66,220
2021-06-11 2021-06-09 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
6,134 -0.3%
3.50
US$21,469 		6,134 -0.3% 3.50 US$21,469
2021-06-08 2021-06-04 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
62,627 -5.4%
3.00
US$187,881 		62,627 -5.4% 3.00 US$187,881
2021-06-08 2021-06-04 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
25,000 -1.3%
2.70
US$67,500 		25,000 -1.3% 2.70 US$67,500
2021-05-28 2021-05-25 PlS Planned sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
147,735 -54.1%
1.91
US$282,174 		147,735 -54.1% 1.91 US$282,174
2021-05-27 2021-05-25 PlS Planned sale
Prince Douglas S
Non-Executive Director
136,539 -37.1%
1.90
US$259,424 		136,539 -37.1% 1.90 US$259,424
2021-05-27 2021-05-25 PlS Planned sale
2.4
Fiorentino Edward
Non-Executive Director
109,231 -24.7%
1.91
US$208,631 		109,231 -24.7% 1.91 US$208,631
2021-05-21 2021-05-19 S Sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
652 -100.0%
2.08
US$1,358 		652 -100.0% 2.08 US$1,358
2021-04-13 2021-04-12 PlS Planned sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
47,580 -98.6%
2.12
US$100,884 		47,580 -98.6% 2.12 US$100,884
2021-04-13 2021-04-12 PlS Planned sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
4,906,326 -100.0%
2.12
US$10,402,883 		4,906,326 -100.0% 2.12 US$10,402,883
2021-04-13 2021-04-09 PlS Planned sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
46,989 -49.3%
2.39
US$112,191 		46,989 -49.3% 2.39 US$112,191
2021-04-13 2021-04-09 PlS Planned sale
4.1
ROEDER DOUGLAS A
Non-Executive Director
4,845,399 -50.0%
2.39
US$11,568,875 		4,845,399 -50.0% 2.39 US$11,568,875
2020-04-29 2020-04-29 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
144,538 -0.7%
0.60
US$87,156 		144,538 -0.7% 0.60 US$87,156
2020-04-29 2020-04-28 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
31,228 -0.2%
0.60
US$18,834 		31,228 -0.2% 0.60 US$18,834
2020-04-29 2020-04-27 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
95,469 -0.5%
0.62
US$59,611 		95,469 -0.5% 0.62 US$59,611
2020-04-23 2020-04-22 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
119,712 -0.6%
0.63
US$75,861 		119,712 -0.6% 0.63 US$75,861
2020-04-23 2020-04-21 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
45,349 -0.2%
0.66
US$29,998 		45,349 -0.2% 0.66 US$29,998
2020-04-20 2020-04-20 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
94,663 -0.5%
0.69
US$65,270 		94,663 -0.5% 0.69 US$65,270
2020-04-20 2020-04-17 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,135 -0.3%
0.68
US$40,241 		59,135 -0.3% 0.68 US$40,241
2020-04-20 2020-04-16 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
49,786 -0.2%
0.67
US$33,416 		49,786 -0.2% 0.67 US$33,416
2020-04-15 2020-04-15 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,569 -0.3%
0.68
US$40,376 		59,569 -0.3% 0.68 US$40,376
2020-04-15 2020-04-14 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
48,564 -0.2%
0.68
US$33,227 		48,564 -0.2% 0.68 US$33,227
2020-04-15 2020-04-13 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
70,184 -0.3%
0.66
US$46,364 		70,184 -0.3% 0.66 US$46,364
2020-04-09 2020-04-09 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
128,301 -0.6%
0.67
US$85,525 		128,301 -0.6% 0.67 US$85,525
2020-04-09 2020-04-08 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
98,802 -0.5%
0.63
US$62,403 		98,802 -0.5% 0.63 US$62,403
2020-04-09 2020-04-07 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
101,116 -0.5%
0.62
US$62,722 		101,116 -0.5% 0.62 US$62,722
2020-04-06 2020-04-06 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
119,929 -0.6%
0.59
US$70,710 		119,929 -0.6% 0.59 US$70,710
2020-04-06 2020-04-03 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,699 -0.3%
0.52
US$31,336 		59,699 -0.3% 0.52 US$31,336
2020-04-06 2020-04-02 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
111,699 -0.5%
0.56
US$62,261 		111,699 -0.5% 0.56 US$62,261
2020-04-01 2020-04-01 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
42,935 -0.2%
0.58
US$24,842 		42,935 -0.2% 0.58 US$24,842
2020-04-01 2020-03-31 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
79,919 -0.4%
0.63
US$50,069 		79,919 -0.4% 0.63 US$50,069
2020-04-01 2020-03-30 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
171,667 -0.8%
0.63
US$108,682 		171,667 -0.8% 0.63 US$108,682
2020-03-27 2020-03-27 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
175,356 -0.8%
0.67
US$116,857 		175,356 -0.8% 0.67 US$116,857
2020-03-27 2020-03-26 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
261,503 -1.2%
0.74
US$192,440 		261,503 -1.2% 0.74 US$192,440
2020-03-27 2020-03-25 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
265,646 -1.2%
0.80
US$212,809 		265,646 -1.2% 0.80 US$212,809
2020-03-18 2020-03-16 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
80,000 -15.5%
0.71
US$56,800 		80,000 -15.5% 0.71 US$56,800
2020-03-11 2020-03-09 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
80,000 -15.8%
1.28
US$102,400 		80,000 -15.8% 1.28 US$102,400
2019-09-11 2019-09-09 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
88,500 +26.3%
1.10
US$97,350 		88,500 +26.3% 1.10 US$97,350
2018-06-21 2018-06-19 PlS Planned sale JAIN Mukul

Chief Operating Officer

Officer
40,000 -100.0%
4.50
US$180,196 		40,000 -100.0% 4.50 US$180,196
2018-06-15 2018-06-15 PlS Planned sale ROEDER DOUGLAS A
5,910 -5.8%
4.05
US$23,930 		5,910 -5.8% 4.05 US$23,930
2018-06-15 2018-06-15 PlS Planned sale ROEDER DOUGLAS A
605,355 -5.8%
4.05
US$2,451,082 		605,355 -5.8% 4.05 US$2,451,082
2018-06-15 2018-06-14 PlS Planned sale ROEDER DOUGLAS A
1,501 -1.5%
3.96
US$5,951 		1,501 -1.5% 3.96 US$5,951
2018-06-15 2018-06-14 PlS Planned sale ROEDER DOUGLAS A
153,723 -1.5%
3.96
US$609,435 		153,723 -1.5% 3.96 US$609,435
2018-06-15 2018-06-13 PlS Planned sale ROEDER DOUGLAS A
2,068 -2.0%
3.96
US$8,199 		2,068 -2.0% 3.96 US$8,199
2018-06-15 2018-06-13 PlS Planned sale ROEDER DOUGLAS A
211,832 -2.0%
3.96
US$839,829 		211,832 -2.0% 3.96 US$839,829
2018-06-13 2018-06-12 PlS Planned sale ROEDER DOUGLAS A
2,536 -2.4%
3.91
US$9,903 		2,536 -2.4% 3.91 US$9,903
2018-06-13 2018-06-12 PlS Planned sale ROEDER DOUGLAS A
259,690 -2.4%
3.91
US$1,014,115 		259,690 -2.4% 3.91 US$1,014,115
Explore more

More insider trading research around Senseonics Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America